Pharmacopsychiatry 2012; 45(04): 164-165
DOI: 10.1055/s-0031-1297938
Letter
© Georg Thieme Verlag KG Stuttgart · New York

Evidence for Pharmacological Management in Delirium

S. Grover
1   Department of Psychiatry, Postgraduate Institute of Medical Education & Research, Chandigarh, India
,
S. K. Mattoo
1   Department of Psychiatry, Postgraduate Institute of Medical Education & Research, Chandigarh, India
,
N. Gupta
2   South Staffordshire Healthcare NHS Foundation Trust, Burton on Trent, United Kingdom
› Author Affiliations
Further Information

Publication History

received 09 November 2011
revised 09 November 2011

accepted 10 November 2011

Publication Date:
15 December 2011 (online)

Abstract

There is limited evidence about the usefulness of antipsychotics and choline esterase inhibitors in delirium. There are very few placebo controlled trials. There is a need to conduct well designed trials to evaluate the efficacy of antipsychotics and choline esterase inhibitors in delirium.

 
  • References

  • 1 Tahir T. A review for usefulness of atypical antipsychotics and cholinesterase inhibitors in delirium. Pharmacopsychiatry. epub ahead of print. 2011 . -
  • 2 Grover S, Mattoo SK., Gupta N. Usefulness of atypical antipsychotics and choline esterase inhibitors in delirium: A review. Pharmacopsychiatry 2011; 44: 43-54
  • 3 Bourne RS, Tahir TA, Borthwick M et al. Drug treatment of delirium: past, present and future. J Psychosom Res 2008; 65: 273-282
  • 4 Tahir TA, Eeles E, Karapareddy V et al. A randomized controlled trial of quetiapine versus placebo in the treatment of delirium. J Psychosom Res 2010; 69: 485-490
  • 5 van Eijk MM, Roes KC, Honing ML et al. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial. Lancet 2010; 376: 1829-1837